At KSQ Therapeutics, we seek to understand the role of every human gene in each disease, each tissue, and each cell that we study. This comprehensive approach has resulted in a massive, experimentally derived dataset that we have found to be remarkably predictive of past successes and failures in oncology and immuno-oncology product development. Utilizing this approach, we also identified a number of opportunities for the development of new medicines. As a result, we have aggressively invested in these distinct, highly validated pathways for new drug development with the expectation that the medicines we create may become the next breakthrough products for patients.
Founded in late 2015, KSQ is a preclinical-stage biotech that has rapidly advanced the field of CRISPR-enabled functional genomics, from in vitro cell autonomous screens to more complex genome-scale screens of immune cells in vivo. The company has expanded the scope of its technology to include multiple cell types and to unlock areas beyond oncology. KSQ is led by a team of accomplished industry experts in drug discovery and development. We maintain a lively and inquisitive environment in the heart of the vibrant Kendall Square neighborhood.
Position Summary:
KSQ Therapeutics, Inc. is seeking a self-motivated and dependable Associate Scientist/Senior Associate Scientist to join our Adoptive Cell Therapy team. Our ideal candidate thrives in a research environment that demands scientific rigor and technical excellence. Applicants with an interest in T cell immunology and expertise in cell culture, CRISPR-Cas9 technology and cell biology are strongly encouraged to apply.
The (Senior) Associate Scientist’s key responsibilities will include the following:
Requirements